EBITDA margin narrowed by 250 basis points to 13.5%, due to increased input and operating costs.
Read More
EBITDA margin narrowed by 250 basis points to 13.5%, due to increased input and operating costs.
The drug is the generic alternative of the Vitamin K1 Injection produced by Hospira Inc and is indicated in the treatment of Vitamin K deficiency-related coagulation disorders.
The fundraising may be executed in one or more tranches using QIP, rights issues, or any other permissible route under regulatory guidelines.
The drug will be manufactured at Lupin's facility in Nagpur, India, and the company has announced plans for a near-term launch in the U.S. market.
Net profit grew 10% sequentially from the last quarter (Q3 FY25) as well, reflecting growth momentum.
The purchase is anticipated to enhance Syngene's position in the biologics contract development and manufacturing organization (CDMO) arena, specifically in the US market.
Here are some of the stocks that may see significant price movement today: Axis Bank, Tech Mahindra, SBI Card & Payments.
UltraTech Cement, Bajaj FinServ, Bajaj Finance are the stocks that hits 52-week high in Sensex and Nifty
On April 23, the Indian equity indices ended on strong note with Nifty above 24,300.
Here are some of the stocks that may see significant price movement today: LTIMindtree, Dalmia Bharat, Bajaj Housing, etc.
Here are some of the stocks that may see significant price movement today: Axis Bank, Tech Mahindra, SBI Card & Payments.
UltraTech Cement, Bajaj FinServ, Bajaj Finance are the stocks that hits 52-week high in Sensex and Nifty
On April 23, the Indian equity indices ended on strong note with Nifty above 24,300.
Here are some of the stocks that may see significant price movement today: LTIMindtree, Dalmia Bharat, Bajaj Housing, etc.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
